If you were the CEO of a pharmaceutical manufacturer that had spent many years andmillions of dollars in creating, developing, testing, and getting government approval for a newdrug, how would you address the issues of protecting your intellectual property while meetingthe patient/public needs for that drug?
Intellectual property (IP) is a significant asset for most companies. Patented products and processes often enable the companys very existence. IP must be managed and protected in line with the fundamentals and mission of a companys business and with the requirements of IP law.
Review Business Ethics Flashpoint 8.1: Creator/Consumer Balance (located at the end of the e-book section on intellectual property, on page 196 (E-book p. 82)). This section of the text portrays negative actions by pharmaceutical and healthcare companies, but there have also been positive examples during the Covid-19 pandemic as companies set aside competitive interests to provide testing, equipment, and research in a more collaborative manner.
The primary balance remains the same: the rights and interests of the creator of the intellectualproperty compared to the needs of the consumers of the product.Question: If you were the CEO of a pharmaceutical manufacturer that had spent many years andmillions of dollars in creating, developing, testing, and getting government approval for a newdrug, how would you address the issues of protecting your intellectual property while meetingthe patient/public needs for that drug?
Consider, e.g.:? Profit and return on investment for company owners/shareholders? Protecting intellectual property of the company? Needs of patients, practitioners, and society? Biblical support and guidance for your positions? Any other legal and ethical concepts you believe may be relevantSupport your analysis with at least 3 scholarly sources other than the course materials, cited in-text and in a reference list. You must also integrate Biblical worldview analysis.
This paper must contain at least and follow current APA format but does notrequire an abstract. The title page and reference list do not count towards the lengthrequirement.
